Treatment Horizons

Stronger Punch? Monoclonal antibodies provide new hope for easier dosing by Jeannie Wraight With multi-drug, once-a-day therapies now available for use, the push for additional easier to...

An extended release formulation breaks through by Chael Needle Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...

LifeGuide Rapid Response Why advances in point-of-care TB diagnostics determine the future of the AIDS crisis by Mariel Selbovitz, MPH   TB—one of the greatest killers and what appears...

Chronic Relief? A self-injectable monoclonal antibody vies to become a monotherapy by Chael Needle Anti-HIV agents currently being researched these days seem split between (1) improving regimens...

Protecting One's Heart The REPRIEVE study aims to prevent cardiovascular disease by Chael Needle As people are living longer with HIV, researchers have been increasingly attending to...

Countdown Researcher Jia Xie discusses a cutting-edge treatment in development by Dann Dulin Block HIV by using the body’s own immune cells? Is it truly possible?! Well, such...

Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients by Chael Needle Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...

Close to the Edit A functional cure candidate modifies genes to create HIV-resistant cells by Chael Needle Gary Blick, MD, AAHIVS, Medical & Research Director of CIRCLE...

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

AIDS Healthcare Foundation Trains a Research Lens on Probiotics by Chael Needle "Probiotics” has become a new buzz word in the dairy aisle—at least two brands...